U/S Pelvis (DC) Diagnostic Scan in Karachi at Dr. Essa Lab

U/S Pelvis (DC) at Dr. Essa Lab

The U/S Pelvis (DC) is a specialized, high-resolution diagnostic imaging examination designed to evaluate the anatomical structures and physiological conditions within the pelvic cavity. Utilizing advanced high-frequency sound waves rather than ionizing radiation, this non-invasive modality provides real-time, detailed visualization of the reproductive and urinary organs. At Dr. Essa Laboratory & Diagnostic Centre, the designation 'DC' signifies Diagnostic Care and the utilization of sterile, single-use Disposable Covers for endocavity transducers, ensuring the highest standards of clinical hygiene, patient safety, and diagnostic precision.

Pelvic ultrasound imaging operates on the principles of acoustic impedance. A specialized transducer emits high-frequency sound waves into the pelvic region. As these waves encounter tissue interfaces of varying densities—such as muscle, fluid, bone, and gas—they are reflected back to the transducer. A sophisticated computer algorithm processes these returning echoes to construct highly detailed, grayscale (B-mode) and color Doppler images. This allows consultant radiologists to assess the size, shape, position, and internal echo-texture of pelvic organs, as well as evaluate real-time blood flow dynamics within pelvic vessels and masses.

For female patients, the U/S Pelvis (DC) provides an exhaustive evaluation of the uterus (including the endometrium, myometrium, and cervix), the ovaries, the fallopian tubes (when pathologically dilated or fluid-filled), and the surrounding pelvic spaces, such as the rectouterine pouch (pouch of Douglas). For male patients, the scan focuses on the urinary bladder, the prostate gland, and the seminal vesicles. The clinical importance of this scan cannot be overstated; it serves as a primary diagnostic tool for investigating pelvic pain, abnormal bleeding, reproductive disorders, and suspected pelvic masses, offering unparalleled diagnostic value with zero radiation exposure.

Clinical Procedure: What to Expect

Patient Preparation

Proper preparation is critical to obtaining high-quality diagnostic images during a U/S Pelvis (DC). The specific preparation depends on whether the scan is performed transabdominally or transvaginally:

• Transabdominal Pelvic Ultrasound: This approach requires a fully distended urinary bladder. Patients must drink approximately 1 to 1.5 liters (32 to 48 ounces) of water or clear fluids one hour prior to the scheduled appointment and refrain from voiding (urinating). A full bladder acts as an 'acoustic window,' displacing the gas-filled bowel loops upward out of the pelvis and allowing the ultrasound waves to pass clearly to the uterus, ovaries, or prostate.
• Transvaginal Pelvic Ultrasound (if clinically indicated): Unlike the transabdominal approach, a transvaginal scan requires a completely empty bladder. Patients will be asked to void immediately before the procedure begins.
• General Guidelines: Patients should wear comfortable, loose-fitting, two-piece clothing to facilitate easy access to the lower abdomen. No dietary restrictions or fasting are required for this examination. Any relevant previous imaging reports or clinical notes should be brought to the appointment.

During the Procedure

Upon entering the ultrasound suite at Dr. Essa Lab, the patient is greeted by a professional sonographer or consultant radiologist. The procedure is conducted in a private, dimly lit room to optimize screen visibility and ensure patient comfort.

For a transabdominal scan, the patient lies supine (on their back) on an examination table. The clinical practitioner applies a warm, hypoallergenic, water-soluble conductive gel to the lower abdomen. This gel eliminates air pockets between the skin and the transducer, facilitating the seamless transmission of sound waves. The practitioner then gently presses the transducer against the skin, moving it systematically across the pelvic region to capture longitudinal and transverse views of the target organs.

If a transvaginal scan is required for superior resolution of the endometrium or ovaries, the practitioner will explain the procedure in detail. The patient lies in a lithotomy position. A slender, specialized transvaginal transducer is covered with a sterile, single-use disposable cover (DC) and lubricated with sterile gel before being gently inserted into the vaginal canal. This method provides exceptionally clear, close-up images because the transducer is positioned closer to the pelvic organs, bypassing abdominal wall fat and bowel gas.

The entire U/S Pelvis (DC) procedure typically takes between 15 and 30 minutes. It is entirely painless, though patients may experience mild pressure from the transducer on a full bladder during the transabdominal phase, or minor pressure during the transvaginal phase. The procedure is highly safe, with no known biological side effects.

When is a U/S Pelvis (DC) Performed?

Evaluating Abnormal Uterine Bleeding

Abnormal uterine bleeding (AUB), including menorrhagia (heavy menstrual bleeding), metrorrhagia (irregular bleeding), and postmenopausal bleeding, is a primary clinical indication for a pelvic ultrasound. The scan allows radiologists to measure endometrial thickness and assess the uterine cavity for structural abnormalities. By identifying conditions such as endometrial hyperplasia, endometrial polyps, or submucosal uterine fibroids, the U/S Pelvis (DC) assists gynecologists in determining whether medical management, endometrial biopsy, or surgical intervention is required.

Investigating Pelvic Pain and Endometriosis

Acute or chronic pelvic pain can arise from a multitude of gynecological, urological, or gastrointestinal etiologies. Physicians request a pelvic ultrasound to localize the source of pain by evaluating the pelvic organs for inflammatory changes, fluid collections, or masses. The scan is highly effective in detecting endometriomas (ovarian cysts filled with altered blood, characteristic of endometriosis), pelvic inflammatory disease (PID), and pelvic congestion syndrome, providing critical diagnostic data to guide targeted therapeutic strategies.

Monitoring Ovarian Cysts and Fibroids

Uterine leiomyomas (fibroids) and ovarian cysts are highly prevalent benign conditions that require careful monitoring. A pelvic ultrasound is utilized to determine the exact size, location (intramural, subserosal, or submucosal for fibroids), and internal characteristics (simple vs. complex for cysts) of these lesions. Serial ultrasound examinations allow clinicians to monitor the growth rate of fibroids and track the resolution or persistence of functional ovarian cysts, preventing unnecessary surgical interventions while ensuring timely treatment when indicated.

Assessing Fertility and Reproductive Health

In patients experiencing infertility or undergoing assisted reproductive technologies (ART), the U/S Pelvis (DC) is an indispensable monitoring tool. It is used to perform follicular tracking (measuring the growth and maturation of ovarian follicles), evaluate endometrial receptivity by measuring endometrial thickness and pattern, and rule out congenital uterine anomalies (such as a septate or bicornuate uterus) that could impede embryo implantation or carry a risk of recurrent pregnancy loss.

Evaluating Urinary Tract and Bladder Issues

In both male and female patients, lower urinary tract symptoms (LUTS)—such as dysuria, urinary frequency, urgency, or hematuria—warrant a pelvic ultrasound. The scan evaluates the urinary bladder's wall thickness, detects the presence of bladder calculi (stones) or masses, and measures the post-void residual (PVR) urine volume to assess bladder emptying efficiency. In male patients, it also provides a precise measurement of prostate gland volume to evaluate for benign prostatic hyperplasia (BPH) or prostatitis.

What Does a U/S Pelvis (DC) Detect?

The U/S Pelvis (DC) is capable of detecting a wide array of pathological conditions, structural anomalies, and physiological changes within the pelvic cavity. Key diagnostic findings include:

• Uterine Leiomyomas (Fibroids): Benign monoclonal tumors of the myometrium, classified by their anatomical location.
• Endometrial Polyps: Benign localized overgrowths of the endometrial stroma and glands projecting into the uterine cavity.
• Endometrial Hyperplasia: Abnormal thickening of the endometrium, which may require biopsy to rule out atypia or malignancy.
• Adenomyosis: The ectopic presence of endometrial tissue within the myometrium, causing diffuse uterine enlargement and a heterogeneous echo-texture.
• Simple Ovarian Cysts: Thin-walled, fluid-filled structures that are typically benign and functional.
• Complex Ovarian Cysts: Cysts containing septations, solid components, or internal echoes, requiring careful evaluation and follow-up.
• Endometriomas: Ovarian cysts containing homogeneous, low-level internal echoes (classic 'ground-glass' appearance) indicative of endometriosis.
• Polycystic Ovarian Morphology (PCOM): Characterized by an increased number of small, peripherally arranged follicles ('string of pearls' sign) and increased ovarian volume.
• Pelvic Inflammatory Disease (PID): Inflammatory changes in the pelvic organs, often associated with free fluid or pelvic abscesses.
• Hydrosalpinx: Fallopian tubes that are distended and filled with simple fluid, indicating tubal blockage.
• Pyosalpinx: Fallopian tubes filled with pus or debris, indicating active pelvic infection.
• Congenital Uterine Anomalies: Structural variations such as bicornuate, septate, subseptate, or didelphys uterus.
• Intrauterine Device (IUD) Malposition: Displacement of an IUD from its proper fundal position within the endometrial cavity.
• Retained Products of Conception (RPOC): Persistent placental or fetal tissue within the uterus following childbirth, miscarriage, or termination.
• Free Fluid in the Pouch of Douglas: Small amounts can be physiological (post-ovulatory), but large volumes may indicate hemorrhage, rupture, or ascites.
• Benign Prostatic Hyperplasia (BPH): Enlargement of the prostate gland, particularly the transition zone, compressing the prostatic urethra.
• Prostatitis: Inflammation of the prostate, often presenting with increased vascularity on color Doppler and heterogeneous echogenicity.
• Seminal Vesicle Distension: Obstruction or inflammation of the seminal vesicles.
• Urinary Bladder Calculi: Highly echogenic structures within the bladder lumen casting a distinct posterior acoustic shadow.
• Bladder Diverticula: Outpouchings of the bladder wall, often secondary to chronic bladder outlet obstruction.
• Bladder Wall Hypertrophy: Thickening of the detrusor muscle, commonly seen in chronic urinary retention or BPH.
• Bladder Masses: Polypoid or sessile mucosal projections into the bladder lumen, which may represent transitional cell carcinoma.
• Post-Void Residual (PVR) Volume: Measurement of retained urine volume immediately after micturition, indicating voiding dysfunction.
• Ovarian Torsion: A surgical emergency suggested by unilateral ovarian enlargement, stromal edema, and absent or diminished Doppler flow.
• Pelvic Varices: Dilated, tortuous pelvic veins associated with pelvic congestion syndrome.

Turnaround Time and Report Access at Dr. Essa Lab

Dr. Essa Laboratory & Diagnostic Centre is highly regarded for its efficient reporting workflow and commitment to clinical excellence. Once the U/S Pelvis (DC) is completed, the captured real-time images and cine loops are thoroughly reviewed by a consultant radiologist. A comprehensive, structured diagnostic report is compiled, detailing all anatomical measurements, physiological observations, and clinical impressions.

At Dr. Essa Lab, preliminary findings are often discussed with the patient immediately following the scan. The finalized, verified written report is typically available within a few hours of the procedure. Patients can conveniently access, download, and share their diagnostic reports and high-resolution digital images online through the secure Dr. Essa Lab patient portal or mobile application. Physical copies of the report, accompanied by high-quality thermal prints of key ultrasound images, can also be collected directly from the diagnostic center where the scan was performed.

U/S Pelvis (DC) Findings Overview

The following table provides a general overview of the clinical parameters evaluated during a pelvic ultrasound, contrasting typical normal findings with potential pathological abnormalities:

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Uterus	Normal size and shape; homogeneous myometrial echogenicity; smooth outer contours.	Enlargement; heterogeneous echogenicity (adenomyosis); focal masses (leiomyomas); congenital structural anomalies.
Endometrium	Thickness varies with menstrual phase (typically 2–14 mm); distinct, regular borders; triple-line appearance in late proliferative phase.	Abnormal thickening (hyperplasia); focal echogenic masses (polyps); irregular borders; fluid in the endometrial cavity.
Ovaries	Normal volume (<10 mL in premenopausal females); presence of normal developing follicles; symmetric blood flow.	Enlarged volume (>10 mL); complex cysts; solid masses; peripheral displacement of multiple small follicles (PCO); absent vascular flow (torsion).
Fallopian Tubes	Typically not visualized unless abnormal.	Visualization of fluid-filled, dilated, or thick-walled tubular structures (hydrosalpinx, pyosalpinx, or ectopic pregnancy).
Urinary Bladder	Anechoic (fluid-filled) lumen; smooth, thin walls (less than 3 mm when fully distended); no internal masses or calculi.	Thickened, trabeculated walls; echogenic calculi with posterior shadowing; mucosal projections (masses); diverticula.
Prostate Gland (Males)	Normal volume (typically <25–30 mL); homogeneous echotexture; smooth, well-defined margins.	Enlarged volume (BPH); heterogeneous echotexture; focal hypoechoic lesions; calcifications; irregular margins.
Pouch of Douglas	No fluid, or a minimal amount of physiological free fluid (especially post-ovulation).	Moderate to large amounts of free fluid; complex fluid with internal echoes (hemoperitoneum or pus); loculated fluid collections (abscess).
Post-Void Residual (PVR)	Minimal or no residual urine remaining in the bladder after voiding (typically <50 mL).	Significant volume of retained urine (indicative of bladder outlet obstruction or detrusor underactivity).

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient's symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Dr. Essa Lab for U/S Pelvis (DC)?

• Established Diagnostic Legacy: Serving patients since 1987, Dr. Essa Lab is one of Pakistan's most trusted and recognized diagnostic networks.
• Expert Radiologists: Scans are performed and interpreted by highly qualified, experienced consultant radiologists and certified sonologists.
• Advanced Ultrasound Technology: Equipped with state-of-the-art, high-resolution ultrasound machines that utilize advanced color Doppler and tissue harmonic imaging.
• Strict Hygiene Standards: The 'DC' protocol ensures the use of sterile, single-use disposable covers for all endocavity probes, preventing cross-contamination.
• ISO Certified Quality: Dr. Essa Lab maintains strict adherence to international quality management systems, ensuring highly accurate and reliable diagnostic reports.
• Rapid Turnaround Time: Finalized, verified diagnostic reports are delivered within hours of the procedure, facilitating prompt clinical decision-making.
• Convenient Digital Access: Patients can easily view, download, and share their reports and images online via the secure patient portal or mobile app.
• Extensive Branch Network: Conveniently located diagnostic centers across Karachi and other major cities, offering easy accessibility and patient-focused care.